Le Lézard
Classified in: Business
Subjects: MAV, FOR, POL, FVT, CFG

Media Advisory - Itinerary for Wednesday, August 21, 2019


OTTAWA, Aug. 20, 2019 /CNW/ -

Note: All times local

 

Montréal, Quebec



11:45 a.m.

The Prime Minister will attend the Montréal Council on Foreign Relations reception.




Closed to media.



1:00 p.m.

The Prime Minister will deliver a keynote speech at the Montréal Council on Foreign Relations event.




Hotel Bonaventure Montréal


900 Rue de la Gauchetière Ouest




Notes for media:




  • Open coverage
  • Media are asked to arrive no later than 12:30 p.m.


2:45 p.m.

The Prime Minister will meet with Mayor of Montréal Valérie Plante.




Montréal City Hall


155 Rue Notre-Dame Est




Notes for media :




  • Open coverage of remarks at the beginning of the meeting
  • Media are asked to arrive no later than 2:15 p.m.

 

This document is also available at http://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: